Exploring the acceptability, appropriateness, feasibility and satisfaction of an implementation strategy for out-of-HOspital administration of the Long-Acting combination of cabotegravir and rilpivirine as an optional therapy for HIV in Spain (the HOLA study)-a hybrid implementation-effectiveness, phase IV, double-arm, open-label, multicentric study: study protocol
探索在西班牙院外使用卡博特韦/利匹韦林长效联合疗法作为HIV可选治疗方案的可接受性、适宜性、可行性和满意度（HOLA研究）——一项混合实施效果、IV期、双臂、开放标签、多中心研究：研究方案
期刊:BMJ Open
影响因子:
doi:10.1136/bmjopen-2024-088514
Negredo, Eugenia; Hernández-Sánchez, Diana; Álvarez-López, Patricia; Falcó, Vicenç; Rivero, Àngel; Jusmet, Javier; Cuerda Palomo, Miguel Ángel; Flores de la Cruz, Ana Belén; Pavón, José Manuel; Llavero, Nadia; Campany, David; Faus, Vicente; Broto-Cortés, Claudia; Bailón, Lucía; Aguilar, Dámaris; Ruiz, Francis; Miranda, Cristina; Puig, Jordi; Rovira, David; Olalla, Julián
